Use of Derivative Spectrophotometry for the in Vitro determination of Phenylbutazone and Oxyphenbutazone in Human Plasma

Abstract

Fourth derivative-difference (ΔD₄.) spectrophoto metry is presented for the simultaneous assay of phenylbutazone and oxyphenbutazone as metabolites of bumadizone either in laboratory made mixtures or in human plasma. Phenylbutazone and oxyphenbutazone are determined through the measurement of ΔD₄ signals at 293 and 282 nm, respectively. The linear relationship of these values versus concentration of both compoundsin the range 1–5 μg/ml for phenylbutazone and 3–8 μg/ml for oxyphenbutazone permits their determination with high accuracy and good reproducibility. The relative standard deviation is less than 1.35% The proposed method could be used for monitoring bumadizone metabolites.     

A Novel Method for the Quantitation of Warfarin and its Metabolites in Plasma

Abstract

A procedure for the rapid, quantitative recovery of warfarin and its metabolites (diastereoisomeric alcohol, 4′-, 6-, 7-, 8-benzylic-hydroxywarfarin and dehydrowarfarin) from plasma with Sep-Pak C₁₈ cartridges has been developed. A solution of warfarin and its metabolites in plasma was acidified with NH₄OAc buffer (pH 4.85), adsorbed on the Sep-Pak C₁₈ resin, washed free of polar constituents and eluted with methanol. Dilution of the eluate with buffer followed by gradient high performance liquid chromatography permitted accurate quantitation of the desired compounds when detected at 313 nm. The recovery of warfarin and each metabolite was greater than 95% over an investigated range of 0.5–10.0 μg/ml of plasma and the limit of quantitation by the assay was 0.1 μg/ml of plasma. For more rapid quantitation of warfarin, without simultaneous analysis of metabolites, the chromatographic parameters were modified so that elution of warfarin occurred within 13 minutes, and the sensitivity of the assay increased to 0.03 μg of warfarin/ml of plasma. The quantitative recovery of warfarin and its metabolites coupled with the chromatographic versatility of the method make it ideally suited for either detailed pharmacokinetic studies or routine plasma analysis of warfarin.     

Determination of Naloxone Hydrochloride in Dosage form by High-Performance Liquid Chromatography

Abstract

A new, sensitive and rapid method for the determination of naloxone hydrochloride as drug in dosage entity and form using HPLC has been developed. Authentic naloxone hydrochloride was used to establish a calibration curve. A linear relationship was obtained for concentrations ranging from 10 μg/ml to 50 μg/ml. The column used was C₁₈, Micropak MCH-10 (monomeric) and the mobile phase was acetonitrile : 0.01 M KH₂PO₄ (70 : 30) at a flow rate of 2 ml/min. Retention time for naloxone hydrochloride was 3.3 minutes. The proposed method has been proved accurate and precise compared to other pharmacopoeia methods of assay for naloxone hydrochloride.     

Solid-Phase Extraction of Carbamazepine and Two Major Metabolites from Plasma for Analysis by HPLC

Abstract

A rapid, sensitive and simple to operate HPLC method for the simultaneous determination of carbamazepine, carbamazepine 10,11-epoxide and 10,11-dihydro-10,11-trans-dihydroxycarbamazepine in plasma is described. The drug and its metabolites are extracted from plasma using commercially available reversed-phase octadecylsilane bonded-silica columns (Bond Elut C₁₈, 2.8 ml capacity). Separation was achieved by reversed-phase chromatography, using a mobile phase consisting of acetonitrile - methanol - water (19:37:44) at a flow-rate of 1.8 ml/min in conjunction with a Waters Assoc. Nova-Pak C₁₈ column. The analytical column, in Radial-Pak cartridge form, was used in combination with a Waters Assoc. Z-module RCSS and protected by a Waters Assoc. Guard-Pak precolumn module containing a Guard-Pak μBondapak C₁₈ insert. Using ultraviolet detection at 214 nm, levels in the region of 50–100 ng/ml for CBZ and its metabolites can be measured with only 250 μl of plasma. The method has been used to determine steady-state concentrations of the drug and its metabolites in paediatric patients.     

An HPLC Method for the Determination of Theophylline and Its Metabolites in Serum and Urine

Abstract

A urine and a serum assay have been developed to quantitate theophylline and its major metabolites:1,3-dimethyluric acid, 3-methylxanthine and 1-methyluric acid. Reverse phase chromatography follows a serum acetone extraction procedure and a urine anion exchange clean-up procedure. Lower limits of sensitivity are 0.04 μg/ml for serum metabolites and 1 μg/ml for urine metabolites. Both assays are free of interference from endogenous substances. These assays have been tested successfully in pharmacokinetic and metabolic studies of theophylline.     

Synthesis of non-toxic anticancer active forskolin-indole-triazole conjugates along with their in silico succinate dehydrogenase inhibition studies

Biologically important three different pharmacophores, forskolin, indole and 1,2,3-triazoles are coupled to obtain a hybrid molecule. Here, we described the synthesis of novel series of forskolin-indole-triazole conjugates 5a-5l by using the Cu(I) catalyzed 1,3-dipolar cycloaddition reaction. Furthermore, the biological significance of the synthesized molecules was assessed by in silico and in vitro modes. All the synthesized compounds were evaluated for in vitro anticancer activity against PC-3, MCF-7, MDA-MB-231, COLO-205, HeLa, WRL-68, RAJI, CHANG and RAW-264.7 cell lines. Compound 5g was found to be the most potent in all the tested cell lines (IC₅₀ range 9.6–21.66 μg/ml, except COLO-205), 5a, 5b and 5k were observed to exert its effect only against WRL-68 (IC₅₀ range 27.69–48.18 μg/ml), when compared to parent 3 (IC₅₀ > 100 μg/ml, tested concentrations 10–50 μg/ml) and standard Doxorubicin (IC₅₀ range 0.42–3.16 μg/ml). The most potent compound 5g (MEF₅₀ 0.57) was found non-toxic to human erythrocytes as compared to control (MEF₅₀ 0.60) at tested concentration (50 μg/ml). In silico-based succinate dehydrogenase inhibition showed that the synthesized compounds were having potent binding affinity compared to forskolin. Predictive ADMET and toxicity risk assessment analysis revealed that most of the compounds were complying with the standard limit of Lipinski's rule of five for oral bioavailability.     

Spectrophotometric Determination of Trimethoprim in Pure Form and in Pharmaceutical Preparations using Bromothymol Blue,Bromocresol Green and Alizarin Red S

ABSTRACT

Simple, sensitive and selective methods for the determination of trimethoprim (TMP) in pure form and in pharmaceutical formulations are described. The methods are based on the reaction of TMP as a π-electron donor with bromothymol blue (BTB), bromocresol green (BCG) and alizarin red S (ARS) as electron acceptors. The coloured products are quantified spectrophotometrically at their corresponding λ_max.

Beer's law is obeyed in case of BTB in the range 2.9-23.2 μg/ml (CHCl₃), 2.9-20.0 μg/ml (CH₂Cl₂) and 5.0-29.0 μg/ml (ClC₆H₅), in the case of BCG 2.9-27.5 μg/ml (H₂O/alc.), 2.9-18.3 μg/ml (CHCl₃) and 2.9-20.3 μg/ml (CH₂Cl₂) and for ARS in the range 3.0-12.0 μg/ml in H₂O/alc medium.

The specific absorptivities, molar absorptivities, Sandell sensitivities, standard deviations and percent recoveries are evaluated. Application of the suggested methods to dosage forms is presented and compared with the pharmacopoeial method. The interference from additives and sulfa compounds, especially sulfamethoxazole, has been overcome by extraction into chloroform or methylene chloride.     

High-Performance Liquid Chromatographic Determination of Acetazolamide in Human Plasma

Abstract

A simple, rapid and specific HPLC method has been developed to determine acetazolamide concentrations in human plasma. The assay procedure requires only 250 μl of sample with direct injection of the organic supernatant after protein precipitation with acetonitrile. Chlorothiazide was used as an internal standard. A reversed-phase C₁₈ μBondapak column was employed for the chromatographic separation. The eluent was monitored at 265 nm using a UV variable wavelength detector. The retention times for acetazolamide (ACZ) and chlorothiazide (CTZ) were 6 and 8 min respectively. A linear relationship (r).995) was obtained over the 1-20 μg/ml concentration range. The limit of sensitivity for ACZ was 0.5 μg/ml, with greater than 85% recovery of ACZ and internal standard. The method was applied to human plasma samples obtained after administration of a 250 mg acetazolamide tablet.     

The Determination of a New Trifluorinated Quinolone,Fleroxacin, Its N-Demethyl,and N-Oxide Metabolites in Plasma and Urine by High Performance Liquid Chromatography with Fluorescence Detection

Abstract

A liquid chromatographic method is described for the determination of the new fluoroquinolone Ro 23–6240 and its N-demethyl and N-oxide metabolites in plasma and urine. The three substances were extracted from aqueous solution with dichloromethane/isopropanol containing sodium dodecyl sulphate. After evaporation and reconstitution, samples were analysed on a reversed-phase column using ion pair chromatography and fluorescence detection. The limit of quantification was 10–20 ng/ml (RSD 4%) using a 0.5 ml plasma sample, and the inter assay precision was 3–10% over the concentration range 50 ng/ml to 20 μg/ml. Recovery from plasma was 81% (RSD 10%) over the range 10 ng/ml to 5 μg/ml. The method has been applied successfully to the analysis of several thousand samples from human pharmacokinetic studies. Care has to be taken to avoid exposure of samples to direct sunlight, and the use of opaque vessels for sample storage and handling is recommended.     

Determination of Formaldehyde in Waste Water by Lucigenin Chemilummescence

Abstract

A chemiluminescence analysis has been developed for the determination of formaldehyde based on its inhibition of the chemiluminescence reaction of lucigenin-C10^?-H₂o₂. The method is sensitive, convenient and selective with a detection limit of 0.05ng/ml. The linear dynamic range is 1.0ng/ml to 0.1 μg/ml. The variation coefficient of ten determinations for 2.Ong/ml formaldehyde is 1.2%. Applications to the trace determination of formaldehyde in industrial waste waters are discussed.     

High-Performance Liquid Chromatographic Determination of SAZ-VII-23, A Novel Antiarrhythmic Agent,in Dog Plasma and Urine

Abstract

A HPLC method has been developed to determine the concentrations of SAZ-VII-23 (3-benzoyl-7-isopropyl-3,7-diazabicyclo[3.3.1]nonane HClO₄), a novel antiarrhythmic agent, in dog plasma and urine. Plasma treated with acetonitrile and alkalinized urine were extracted with chloroform- propanol (9:1). An aliquot was injected on to HPLC system using a C₆ reversed-phase column and acetonitrile-methanol-37.5 mM phosphate buffer, pH 6.8 (28.5:28.5:43 v/v) containing 4.0 mM triethylamine as mobile phase. Detection wavelength was 255 nm. The linear range were 0.04–8 μg/ml, and the lower limit of quantitation was 0.04 μg/ml in plasma and urine, respectively. The method was applied to determine plasma and urine concentrations and preliminary pharmacokinetic profiles of SAZ-VII-23 in a dog.     

Determination of Toxic Organophosphorus Compounds by Specific and Nonspecific Detectors

Abstract

Sample preparation procedures and gas chromatography methodology are presented for the determination of tabun, sarin, soman, and VX in aqueous solutions. Extraction recoveries from chloroform were quantitative. Peak area ratios of organophosphorus compounds (OPs) to internal standard versus concentrations of OP were linear over the range of 10-1000 (μg/ml when determined by the flame ionization detector and 10-800 μg/ml when determined by the flame photometric detector. Imprecision occurring at low ng concentrations of VX was caused by its adsorption on the analytical column. Acceptable precision was regained by the addition of a weak base, such as atropine, to the sample extract prior to its injection onto the gas chromatograph (GC).     

Determination of Ascorbic Acid and Dehydroascorbic Acid in Blood Plasma Samples

Abstract

Following the stabilization of the plasma samples with HClO₄ and EDTA, the samples could be directly analyzed by HPLC using electrochemical detection and reversed-phase columns. The accuracy and precision of the method was evaluated using plasma samples spiked with ascorbic acid (10 μg/ml) and the results were also compared to the classical colorimetric procedure. Dehydroascorbic (5 μg/ml) was determined in plasma samples using UV detection following derivatization at room temperature for 45 minutes with o-phenylenediamine.     

Simultaneous Quantitation of Minoxidil and Tretinoin in Magistral and Pharmaceutical Preparations by First Derivative Spectrophotometry

Abstract

A first derivative spectrophotometry method has been developed for the simultaneous quantitation of minoxidil and tretinoin. The method is based on measuring the first derivative signals (D₁) of minoxidil and tretinoin at 290 and 351 nm, respectively, without any interference from each other, or any other coexisting materials. Beer's law was valid over the concentration range 2–10 μg/ml of minoxidil and 0.25–1.25 μg/ml of tretinoin. The proposed method has been applied successfully to the determination of some magistral and pharmaceutical preparations. Relative standard deviations for the assay of both drugs were less than 0.95%.     

Simultaneous Determination of Micro Bromide and Iodide by Kinetic Spectrophotometric Method

ABSTRACT

ABSTRACTA new kinetic spectrophotometric method for the simultaneous determination of concentrations of micro bromide and iodide has been proposed. It is based on their catalytic effects on the reaction of m-cresol purple oxidized by potassium periodate in hydrochloride acid medium. The reaction rate was monitored by measuring the decrease in absorbance at 528nm and the increase in absorbance at 455nm. The total difference in absorbance of the sum of bromide and iodide is identical with determination of bromide was carried out after Cr(VI) oxidized I? to I₂, and I₂ was removed by extraction with CCI₄, and the amount of iodide was measured by subtracting the absorbance change of bromide from the total absorbance change in the presence of bromine and iodide. The optimum conditions influencing the reaction rate were studied. The linear range of determination is 0～4.0μg/ml for Br? and 0～3.0 μg/ml for I?. The detection limits are 0.032μg/ml for Br? and 0.059 μ/ml for I?. The method was successfully applied to the determination of micro amounts of bromide and iodide in food and life samples.     

Spectrophotometric Assay of Certain Cephalosporins Based on Formation of Ethylene Blue

Abstract

The hydrolytic degradation of antibiotics is very often used as a preliminary step in the analytical procedures for their determination. Therefore, a procedure was developed for measuring small amounts of cefadroxil and cefotaxime in pure samples as well as in formulations.

The method depends on forming a vis-absorbing compound with N,N-diethyl-p-phenylenediamine sulphate (N,N-DPPD) (ethylene blue dye), after the hydrolysis of cefadroxil and cefotaxime in sodium hydroxide solution to give hydrogen sulphide. The method is selective for cephalosporins, since other β-lactam compounds such as penicillins do not give hydrogen sulphide under alkaline hydrolysis. Variables such as pH, temperature, reagent concentrations and stability of the colour produced have been evaluated to permit selection of the most advantageous technique. Beer's law obeyed over the concentration range 0.5–10 μg/ml and 0.5–7 μg/ml for cefadroxil and cefotaxime, respectively. The detection limit being 0.1 μg/ml and 0.05 μg/ml (defined as the amount of the drug that gave a signal of twice the background noise) for cefadroxil and cefotaxime, respectively. The method has been successfully applied to the analysis of some pharmaceutical formulations.

The results have been statistically compared with those obtained by the official method. The relative standard deviation (for 10 replicates) was 1.12 (9 μg/ml) and 0.49% (5 μg/ml) for cefadroxil and cefotaxime, respectively. Procedural details and data for the effect of operating parameters are presented.     

Bioanalysis of Naproxen by High Performance Reversed Phase Liquid Chromatography with Photometric and Fluorimetric Detection

Abstract

Methods for the quantitative determination of NAPROXEN and its main metabolite in plasma and urine are described. The separation is based on reversed phase liquid chromatography with LiChrosorb RP 8 (5 μm) as the support and methanol/phosphate buffer pH 7 as mobile phase, in some cases with addition of tetrabutyl ammonium ion as ion-pairing agent to improve the chromatographic selectivity. With UV-detector and a simple filter fluorometer an extraction-evaporation procedure is used for both plasma and urine determinations, while the high selectivity and sensitivity of a sophisticated fluorescence detector permits the direct injection of diluted samples on to the column. Use of an internal standard improves the within-run precision (s_rel%), which for plasma determinations of NAPROXEN are - with UV-detection, 0.2 – 1.7% (range 10 – 40 μg/ml), with filter fluorometer, 2.4 – 5.9% (range 12 – 58 μg/ml), and with fluorescence detector, 0.8 – 4.1% (range 5 – 20 μg/ml).     

Size Exclusion Chromatographic Determination of PEG 3350 in Human Plasma and Urine

Abstract

A size exclusion chromatographic method is reported that quantitated PEG 3350 in human plasma and urine to a concentration of 10 μg/ml in plasma, or urine. The chromatographic system consisted of a 500 A gel permeation analytical column, a differential refractometer detector, and chloroform as the eluting solvent. Organic extraction was used as an initial separation technique. PEG 400 was used as the internal standard for PEG 3350, and showed similar extraction properties. Spiked plasma standards yielded standard calibration curves with correlation coefficients of greater than 0.99, and relative standard deviations (n=3) of 2.19% (500 μg/ml) and 6.97% (20 μg/ml). The analytical technique was used to estimate the elimination rate constant of PEG 3350 from 5 normal human subjects after oral administration of 240 grams of PEG 3350. K_E was found to be 0.1079 hr^?1 0.03781^?1 hr (mean s.d.) using the Sigma-minus data analysis method on total urines collected from the 5 subjects at varying intervals.     

Simultaneous Determination of Tinidazole and Furazolidone in Suspension by HPTLC and HPLC

Abstract

High performance thin layer chromatographic (HPTLC) and high performance liquid chromatographic (HPLC) methods were developed for the simultaneous determination of Tinidazole and Furazolidone in suspension.

In the HPTLC method the separation of Tinidazole and Furazolidone was carried out on silica gel 60F₂₅₄ HPTLC glass plate using chloroform:methanol:ammonia (9:1:0.1 v/v) as a mobile phase. Rf values obtained were 0.63 and 0.79 for Furazolidone and Tinidazole respectively. Densitometric evaluation was done at 335 nm. Linearity was obtained within the concentration range 10–50 μg/ml and 3.5–17.5 μg/ml for Tinidazole and Furazolidone respectively.

The second method is based on high performance liquid chromatography on a reversed phase column (μ Bondapak C₁₈) using a mobile phase comprised of water: acetonitrile: triethylamine (80:20:0.1 v/v) adjusted to pH = 3.0 with dil. phosphoric acid. Retention times were 5.24 and 7.82 min for Tinidazole and Furazolidone respectively at a flow rate of 1.5 ml/min. Detection was done at 335 nm. Linearity was obtained within the concentration range 30–180 μg/ml and 10.5–63 μg/ml for Tinidazole and Furazolidone resp.     

Total Sulfur Concentration in Tissues of Control and Cadmium-Exposed Rats by Inductively Coupled Plasma Atomic Emission Spectrometry

Abstract

Total sulfur (S) concentration in biological samples was determined simultaneously with metal concentrations by inductively coupled plasma-atomic emission spectrometry (ICP).

A 0.2 g portion of liver and other tissues were wet-digested with 1.0 ml mixed acid (HNO₃ : HCLO₄ = 5 : 1, v/v) at 130 – 150 °C. The solution was concentrated to about 0.1 ml and then diluted to 5.0 ml with double distilled water. Concentration of S was determined by ICP using ammonium sulfate as a standard S compound. Sulfur and other element concentrations in an NBS standard reference material (Bovine Liver SRM 1577) were within the certified values by this method.

Concentrations of total S, cadmium (Cd), copper (Cu) and zinc (Zn) in the liver, kidney, spleen, lung, pancreas and blood serum were compared between the control and Cd-exposed rats. The three metal concentrations were increased significantly by Cd exposure. However, S concentration was not altered significantly in the liver and other tissues despite the extensive induction of metallothionein (MT) by the repeated Cd exposure. Metallothionein induced by the accumulated Cd (121 μg/g) and Zn (48 μg/g) in the liver was estimated to account for at maximum 7 % of the total S by assuming that the increased metals were all bound to MT. Concentration of S in blood serum was decreased significantly by Cd loading.